Stem Cells International (Jan 2024)

Identification of a Novel Mesenchymal Stem Cell–Related Signature for Predicting the Prognosis and Therapeutic Responses of Bladder Cancer

  • Enguang Yang,
  • Luhua Ji,
  • Xinyu Zhang,
  • Suoshi Jing,
  • Pan Li,
  • Hanzhang Wang,
  • Luyang Zhang,
  • Yuanfeng Zhang,
  • Li Yang,
  • Junqiang Tian,
  • Zhiping Wang

DOI
https://doi.org/10.1155/sci/6064671
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusions: The five-gene MSC prognostic model demonstrates substantial efficacy in prognosticating clinical outcomes and gauging responsiveness to chemotherapy and immunotherapy regimens. The genes ZNF165, MXRA7, CEMIP, ARL4C, and CERCAM are underscored as promising candidates warranting further exploration for anti-MSC therapeutic strategies, thereby offering novel insights for personalized treatment approaches in BC.